Diagnosis of Skin Disease by Nondermatologists

Alan B. Fleischer, Jr, MD;Courtney-Regan Herbert, MPH;Steven R. Feldman MD, PhD;Frances O'Brien, MD;

Publication

Article

October 1, 2000

The American Journal of Managed Care

October 2000

Volume6

Issue 10

Diagnosis of Skin Disease by Nondermatologists

Author(s):

Alan B. Fleischer, Jr, MD,Courtney-Regan Herbert, MPH

Download PDF: Diagnosis of Skin Disease by Nondermatologists

Articles in this issue

A Comparison of Medicare Fee-for-Service and a Group-Model HMO in the Inpatient Management and Long-Term Survival of Elderly Individuals with Syncope

Follow-Up Among Women with an Abnormal Mammogram in an HMO: Is It Timely, Complete, and Efficient?

Accrediting Organizations and Quality Improvement

Efficient Evaluation of Thyroid Nodules by Primary Care Providers and Thyroid Specialists

Therapeutic Substitution of Cimetidine for Nizatidine Was Not Associated with an Increase in Healthcare Utilization

Diagnosis of Skin Disease by Nondermatologists

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

September 9th 2025

Impact of More Primary Care Visits on Commercial Health Care Costs

Tory M. Wolff, MBA Jacob Wiesenthal, BA

September 9th 2025

State Restrictions on Prior Authorization

David H. Howard, PhD Alissa Durakovic

September 9th 2025

Managed Care Reflections: A Q&A With Dora Hughes, MD, MPH

Dora Hughes, MD, MPH Christina Mattina

September 9th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 9th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 9th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

Related Content

September 9th 2025

Impact of More Primary Care Visits on Commercial Health Care Costs

Tory M. Wolff, MBA Jacob Wiesenthal, BA

September 9th 2025

State Restrictions on Prior Authorization

David H. Howard, PhD Alissa Durakovic

September 9th 2025

Managed Care Reflections: A Q&A With Dora Hughes, MD, MPH

Dora Hughes, MD, MPH Christina Mattina

September 9th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 9th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 9th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

Diagnosis of Skin Disease by Nondermatologists

Newsletter